Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12036-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CHI3L1/YKL40 antibody
- Antibody type
- Polyclonal
- Description
- CHI3L1/YKL40 antibody (Cat. #12036-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Effects of chitinase-3-like protein 1 on brain death-induced hepatocyte apoptosis via PAR2-JNK-caspase-3.
Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment.
MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases.
LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis.
BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway.
SSEA-4 and YKL-40 positive progenitor subtypes in the subventricular zone of developing human neocortex.
Li ZX, Yang DJ, Huo ZK, Wen PH, Hu BW, Wang ZH, Guo WZ, Zhang SJ
Biochemical and biophysical research communications 2021 May 7;552:150-156
Biochemical and biophysical research communications 2021 May 7;552:150-156
Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment.
Shan Z, Li L, Atkins CL, Wang M, Wen Y, Jeong J, Moreno NF, Feng D, Gui X, Zhang N, Lee CG, Elias JA, Lee WM, Gao B, Lam FW, An Z, Ju C
eLife 2021 Jun 10;10
eLife 2021 Jun 10;10
MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases.
Shi Y, He W, Zhong M, Yu M
Genomics 2021 Jul;113(4):1988-1998
Genomics 2021 Jul;113(4):1988-1998
LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis.
Liu W, Yang YJ, An Q
Cancer management and research 2020;12:463-473
Cancer management and research 2020;12:463-473
BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway.
Sha Z, Zhou J, Wu Y, Zhang T, Li C, Meng Q, Musunuru PP, You F, Wu Y, Yu R, Gao S
Frontiers in oncology 2020;10:565225
Frontiers in oncology 2020;10:565225
SSEA-4 and YKL-40 positive progenitor subtypes in the subventricular zone of developing human neocortex.
Brøchner CB, Møllgård K
Glia 2016 Jan;64(1):90-104
Glia 2016 Jan;64(1):90-104
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CHI3L1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CHI3L1. This antibody recognizes human,mouse,rat antigen. The CHI3L1 antibody has been validated for the following applications: ELISA, IHC analysis.
